Coronavirus (COVID-19) Preparedness Information Learn More
Conemaugh Memorial Medical Center announced today a new state-of-the-art molecular lab located on the first floor of the Good Samaritan building. The introduction of this lab gives Conemaugh Memorial the ability to expand its specialty laboratory capabilities and also support molecular testing for other hospitals across the country.
“Conemaugh already provides a variety of laboratory testing services for our patients, allowing for quick turnaround time for diagnosis,” said Tony Campagna, Vice President of Ancillary, Post-Acute, and Support Services at Conemaugh Memorial. “Adding the molecular lab allows us to process advanced molecular testing in-house while increasing efficiency and decreasing costs.”
The local investment by LifePoint Health for the molecular lab totaled more than $1.7 million.
In addition to performing testing for local patients, Conemaugh Memorial will also accept specimens for advanced molecular testing from hospitals and health systems across the country. “Our staff is experienced and well-equipped to provide this important patient service, and it is a privilege to be able to extend these services to others,” said Lary Koval, System Director of Laboratory Medicine at Conemaugh Memorial. “Most importantly, our physicians will be able to start treatment plans earlier due to the quicker turn-around-times associated with these onsite capabilities. We look forward to developing and growing our molecular program over time.”
Conemaugh Memorial Laboratory Services
Conemaugh Memorial offers robust laboratory services that are accredited by The Joint Commission and the AABB for Transfusion Medicine. Benefits of accreditation include validating the lab’s strong patient safety program and reinforcing the community’s confidence in the quality and safety of care, treatment, and services provided by Conemaugh’s laboratory. Accreditation by The Joint Commission also verified the robust performance excellence plan in place by Conemaugh’s laboratory.